Management tracks

Oncology play Bind Therapeutics Inc. (NASDAQ:BIND) named Andrew Hirsch as acting president and CEO. Hirsch, formerly Bind's COO and CFO, replaces Scott Minick, who will remain on Bind's board. The company also appointed Dan Koerwer as CBO. Koerwer was Bind's SVP of business development and commercial.

Genkyotex S.A. (Plan-les-Ouates, Switzerland) hired Elias Papatheodorou as CBO. He was CBO of Covagen AG, which was acquired by Johnson & Johnson (NYSE:JNJ). ...